Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

US Patent 10975153 · Granted Apr 13, 2021

Estimated economic value: $113,156,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of making afucosylated anti-FGFR2IIIB antibodies2025
Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer2025
Screenshot method and related device2025
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for can2023
FGFR2 inhibitors alone or in combination with immune stimulating agents in cance2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Illumination method and equipment for optical imaging2022